← Back to Search

Dance for Autism (Dance and NDDs Trial)

N/A
Recruiting
Led By Rujuta B Wilson, MD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A diagnosis of a neurodevelopmental disorder
Children must be between the ages of 4 to 17
Must not have
Children without a neurodevelopmental disorder
Children younger than 4 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trialexplores whether dance/creative movement classes improve motor skills, success in other tasks, quality of life & adaptive function in children with neurodevelopmental disorders.

Who is the study for?
This trial is for children aged 4 to 17 with a neurodevelopmental disorder, such as autism. It's open to all genders and ethnicities. Kids who've already taken dance classes through the Expressive Movement Initiative or are outside the age range can't participate.
What is being tested?
The study tests how dance affects motor skills, confidence in achieving goals, quality of life, adaptive function, and social communication in kids with autism. They'll attend weekly dance classes for 10 weeks and have assessments before and after the program.
What are the potential side effects?
Since this trial involves dance classes rather than medication, traditional side effects aren't expected. However, participants may experience fatigue or muscle soreness from physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a neurodevelopmental disorder.
Select...
My child is between 4 and 17 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child does not have a neurodevelopmental disorder.
Select...
My child is under 4 years old.
Select...
I am older than 17 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Autism Impact Measure
Brief Observation of Social Communication Change
Lifespan Self-Esteem Scale
+6 more
Secondary study objectives
Social responsiveness scale
Survey for adults
Survey for children

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Waitlist ControlExperimental Treatment1 Intervention
This group will receive the intervention in the second 10 weeks of the study (after the active group and after pre-post assessments in the first 10 weeks during the time of no intervention).
Group II: Active GroupActive Control1 Intervention
This group will receive the intervention in the first 10 weeks of the study. The intervention is a dance intervention that consists of a series of expressive movements.

Find a Location

Who is running the clinical trial?

Health Resources and Services Administration (HRSA)FED
85 Previous Clinical Trials
151,613 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,567 Previous Clinical Trials
10,266,960 Total Patients Enrolled
Rujuta B Wilson, MDPrincipal InvestigatorUniversity of California, Los Angeles

Media Library

Dance Clinical Trial Eligibility Overview. Trial Name: NCT04762290 — N/A
Neurodevelopmental Disorder Research Study Groups: Active Group, Waitlist Control
Neurodevelopmental Disorder Clinical Trial 2023: Dance Highlights & Side Effects. Trial Name: NCT04762290 — N/A
Dance 2023 Treatment Timeline for Medical Study. Trial Name: NCT04762290 — N/A
~8 spots leftby Dec 2025